Dublin, March 20, 2019 (GLOBE NEWSWIRE) -- The "Drug Discovery and Therapy World Congress 2019 - Corporate" conference has been added to ResearchAndMarkets.com's offering.
This conference will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery and therapy and promises to be a large event with up to 400 lectures in 45 thematic sessions with an allied poster presentation.
At the 2019 congress, the major topics of discussion related to drug, discovery and therapy will include: Pharmaceutical Research & Development, Translational Medicine, Regenerative Medicine, Enabling Technologies, Structural Biology, Drug Delivery & Targeting, Antiinfectives, Biologics, CNS Drug Discovery & Therapy, Diabetes and Obesity Drug Discovery & Therapy, Women's Health Drug Discovery & Therapy, Drug Discovery in Preclinical Research, Cardiovascular Drug Discovery & Therapy, Oncology, Process Chemistry and Drug Manufacturing, Pulmonary Drug Discovery & Therapy, Recent Advances in Patient Treatment and Care, Inflammation and Immunology, Innovative Drug Discovery and Nanotechnology, Pharmaceutical Biotechnology, Proteomics & Bioinformatics, Pharmacogenomics, Protein and Peptide Sciences, Drug Metabolism, Hot Topics in Medicinal Chemistry, Medical Imaging, Hot Topics in HIV Research, In-silico Drug Design and in-silico screening, Combinatorial Chemistry, High-throughput Screening & Laboratory automation, Hot Topics in Drug Targets, Hot Topics in Natural Products, Stereoselective Synthesis of Bioactive Compounds, Recent Advances in Spectroscopy, Academic CRO/Industrial collaborations in drug discovery.
The conference aims to provide many interesting perspectives on how science and technology of drug discovery and drug therapy are changing rapidly, thereby providing new opportunities and challenges to scientists and medical doctors.
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
Throughout the course of the three day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers from the international pharmaceutical, academic and clinical communities.
Benefits of Attending
- Exchange ideas and network with leading pharmaceutical scientists and clinicians.
- Brings together top international scientists and clinicians presenting cutting-edge discoveries, research and new therapeutic drugs.
- This conference aims to span the interdisciplinary fields of pre-clinical and clinical drug discovery and drug therapy and to highlight the burgeoning fields of Translational Medicine - and the major advances from "bench to bedside" research and practice.
- Participants can gain direct access to a core audience of professionals and decision makers and can increase visibility through branding and networking at the conference.
- Obtain a global roundup of Pharmaceutical research capabilities and opportunities.
Who Should Attend:
The conference will appeal to a targeted group of scientists and senior international decision makers. Delegates will have a valuable, informative and positive experience.
- Pharmaceutical scientists
- Clinicians/Doctors
- CEOs, CROs, senior instrumental professionals directors and research associates from the pharmaceutical industry and academia
Speakers
Plenary Speaker
Ferid Murad (President) (Nobel Laureate)
The Stanford VA Hospital, Palo Alto, CA, USA
Jean-Marie Lehn (Nobel Laureate)
Institut de Science et d'Ingnierie Supramolculaires, Universit de Strasbourg, France
Dimitris Roukos
Professor of Surgery and Precision Cancer Genome Medicine Founding Director Centre for BioSystems and Genome Network Medicine Ioannina University, School of Medicine Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece
Ada Yonath (Nobel Laureate)
Department of Structural Biology, Weizmann Institute, Rehovot 76100, Israel
Charles N. Serhan
Center for Experimental Therapeutics and Reperfusion Injury Brigham and Women's Hospital and The Simon Gelman Professor of Anaesthesia (Biochemistry & Molecular Pharmacology) Harvard Medical School
& Oral Medicine, Infection and Immunity Harvard School of Dental Medicine
U.S.A.
Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering M.I.T., Depts. of Mechanical Engineering and Biological Engineering 77 Massachusetts Ave, NE47-321 Cambridge, MA 02139, USA
keynote Speakers
D.K. Lahiri USA
Department of Psychiatry and of Medical & Molecular Genetics, IADC, Indiana University School of Medicine, Indianapolis, IN, USA
M.I. Choudhary Pakistan
H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan
Rakesh Kumar India
Cancer Biology Program, Rajiv Gandhi Center of Biotechnology, Thiruvananthapuram 695014, India
For more information about this conference visit https://www.researchandmarkets.com/research/bp3jdr/world_drug?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.